Literature DB >> 28188576

Anti-phospholipid syndrome therapy.

Antonio Ponzetto1, Natale Figura2, Andrea Caccioppo3.   

Abstract

Mesh：

Year:  2017        PMID： 28188576     DOI： 10.1007/s11739-017-1633-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  4 in total

1.  Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication.

Authors:  V Cicconi; E Carloni; F Franceschi; R Nocente; N G Silveri; R Manna; S Servidei; A R Bentivoglio; A Gasbarrini; G Gasbarrini
Journal:  Am J Med       Date:  2001-08       Impact factor: 4.965

Review 2.  Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome.

Authors:  Savino Sciascia; Massimo Radin; Mario Bazzan; Dario Roccatello
Journal:  Intern Emerg Med       Date:  2017-01-02       Impact factor: 3.397

3.  Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation.

Authors:  Simona Cardaropoli; Alessandro Rolfo; Annalisa Piazzese; Antonio Ponzetto; Tullia Todros
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

4.  Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis.

Authors:  Francesco Franceschi; Antonia R Sepulveda; Antonio Gasbarrini; Paolo Pola; Nicolò Gentiloni Silveri; Giovanni Gasbarrini; David Y Graham; Robert M Genta
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690
  4 in total
  1 in total

1.  Antiphospholipid antibodies: crossroads between autoimmunity and infections?

Authors:  Savino Sciascia; Massimo Radin; Mario Bazzan; Dario Roccatello
Journal:  Intern Emerg Med       Date:  2017-04-12       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.